US infectious ailments agency BARDA is supporting to fund the trial with a grant value up to $72.5mln. (NASDAQ:SMMT) explained...
US infectious ailments agency BARDA is supporting to fund the trial with a grant value up to $72.5mln. (NASDAQ:SMMT) explained...
WhatsApp us